Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,6413,660 of 20,252 grants

Active NON-SBIR/STTR RPGS
Targeting PP4 to improve ovarian cancer response to immunotherapy
NATIONAL CANCER INSTITUTE Mayo Clinic Arizona United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT High-grade serous ovarian cancer has the highest mortality rate of all gynecologic cancers. There is a critical unmet need to identify new therapeutic targ...

$5.11M
USD
Completed TRAINING, INDIVIDUAL
Defining a novel subset of metastasis-associated monocytes
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2025

Project Summary/Abstract Metastasis is a feature of advanced disease whereby tumor cells spread to distant parts of the body, and is responsible for the vast majority of cancer-rel...

$446.3K
USD
Completed SBIR-STTR RPGS
Light-directed therapy of squamous cell head and neck cancer with a novel dual-acting chemotherapeutic.
NATIONAL CANCER INSTITUTE Light Switch Bio, Llc United States 2023 – 2025

PROJECT SUMMARY. In this Phase I STTR project, Light Switch Bio will collaborate with Virginia Commonwealth University and the University of Pennsylvania for the early-stage develo...

$4.06M
USD
Active RESEARCH CENTERS
Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – OVERALL The partnership center, entitled Partnership to Assess Viral and Immune Landscape Intersections with Oncology (PAVILION) for People Living with HIV Progra...

$11.09M
USD
Active RESEARCH CENTERS
Administration & Coordinating Core
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – ADMINISTRATIVE & COORDINATING CORE The Administrative & Coordinating (AC) Core for the Partnership to Assess Viral and Immune Landscape Intersections with...

Active RESEARCH CENTERS
Project 1: Exploring viral and immunological factors of HPV associated cancers in PLWH and its relation to survival
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – PROJECT 1 People living with HIV (PLWH) have significantly higher cancer incidence compared to people without HIV for cancers caused by HPV (cervical, vulvar, ana...

Active RESEARCH CENTERS
Project 2: Novel investigation of Epstein-Barr virus as a potential cause of conjunctival squamous cell carcinoma among people living with HIV in Zimbabwe
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – PROJECT 2 Conjunctival squamous cell carcinoma (cSCC) is an eye cancer with unknown etiology. cSCC disproportionately impacts Sub-Saharan Africa (SSA), a setting...

Active RESEARCH CENTERS
Data Management & Statistical Core
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – DATA MANAGEMENT & STATISTICS CORE The overarching goal of the Data Management & Statistics Core (DMSC) for the Partnership to Assess Viral and Immune Land...

Active RESEARCH CENTERS
Central Laboratory Core
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – CENTRAL LABORATORY CORE The overarching goal of the Central Laboratory (CL) Core for the Partnership to Assess Viral and Immune Landscape Intersections with Oncol...

Active RESEARCH CENTERS
Developmental & Career Enhancement Core
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – DEVELOPMENTAL CORE The overarching goal of the Developmental Core (DC) for the Partnership to Assess Viral and Immune Landscape Intersections with Oncology for Pe...

Completed OTHER RESEARCH-RELATED
Molecular dissection of extrachromosomal DNA formation, development, and evolution
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2025

PROJECT SUMMARY / ABSTRACT The devastation wrought by cancer derives primarily from the capacity of tumor cells to evolve. Metastasis, immune evasion, treatment resistance, and eve...

$1.26M
USD
Active NON-SBIR/STTR RPGS
Targeting PP4 to improve ovarian cancer response to immunotherapy
NATIONAL CANCER INSTITUTE Mayo Clinic Arizona United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT High-grade serous ovarian cancer has the highest mortality rate of all gynecologic cancers. There is a critical unmet need to identify new therapeutic targ...

$4.34M
USD
Active NON-SBIR/STTR RPGS
Randomized clinical trial to test the efficacy of a smartphone app for smoking cessation for nondaily smokers
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2028

Project Summary Nondaily smoking is an increasingly prevalent pattern of smoking with substantial health detriments. Currently, 25% of all U.S. adult smokers are nondaily smokers,...

$6.52M
USD
Active NON-SBIR/STTR RPGS
In vivo Evaluation of Lymph Nodes Using Quantitative Ultrasound
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

Project Summary This application proposes a collaborative study to be performed by Weill Cornell Medicine (WCM) in New York, NY, as the lead organization in collaboration with GE R...

$7.36M
USD
Active NON-SBIR/STTR RPGS
Signaling basis of senescence-associated secretory phenotype and its implications in epithelial ovarian cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

Project Summary Cellular senescence is a tumor-suppressive cell growth arrest triggered by inducers such as stand-of-care epithelial ovarian cancer (EOC) chemotherapeutic platinum,...

$4.95M
USD
Active NON-SBIR/STTR RPGS
SUMOylation disruption is toxic for SS18-SSX-driven synovial sarcoma
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

Project Summary: Synovial Sarcoma (SS) is driven by the SS18-SSX oncofusion, and SS18-SSX is the only reoccurring mutation in SS. SS normally metastasizes, resulting in a 15-year o...

$5.25M
USD
Active NON-SBIR/STTR RPGS
Identification of small molecule inhibitors to exonuclease 1 for breast cancer treatment
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2026

ABSTRACT Our overall goal, which is fully responsive to PAR-20-271, is to develop a selective and effective inhibitor of the multi-functional DNA repair enzyme exonuclease 1 (EXO1)...

$6.1M
USD
Completed OTHER RESEARCH-RELATED
Investigating the interplay between senescence and T cell immunity
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT CANDIDATE: One of my long-standing interests is to understand the mediators of a successful antitumoral T cell response. In this application, I am proposin...

$1.43M
USD
Active NON-SBIR/STTR RPGS
Signaling basis of senescence-associated secretory phenotype and its implications in epithelial ovarian cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

Project Summary Cellular senescence is a tumor-suppressive cell growth arrest triggered by inducers such as stand-of-care epithelial ovarian cancer (EOC) chemotherapeutic platinum,...

$5.22M
USD
Active NON-SBIR/STTR RPGS
Identification of small molecule inhibitors to exonuclease 1 for breast cancer treatment
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2026

ABSTRACT Our overall goal, which is fully responsive to PAR-20-271, is to develop a selective and effective inhibitor of the multi-functional DNA repair enzyme exonuclease 1 (EXO1)...

$5.75M
USD